252 related articles for article (PubMed ID: 37351597)
1. PARP2 promotes inflammation in psoriasis by modulating estradiol biosynthesis in keratinocytes.
Antal D; Pór Á; Kovács I; Dull K; Póliska S; Ujlaki G; Demény MÁ; Szöllősi AG; Kiss B; Szegedi A; Bai P; Szántó M
J Mol Med (Berl); 2023 Aug; 101(8):987-999. PubMed ID: 37351597
[TBL] [Abstract][Full Text] [Related]
2. Poly(ADP-ribose) polymerase-1 depletion enhances the severity of inflammation in an imiquimod-induced model of psoriasis.
Kiss B; Szántó M; Hegedűs C; Antal D; Szödényi A; Márton J; Méhes G; Virág L; Szegedi A; Bai P
Exp Dermatol; 2020 Jan; 29(1):79-85. PubMed ID: 31755591
[TBL] [Abstract][Full Text] [Related]
3. Sinomenine Suppressed Keratinocyte Proliferation and Imiquimod-Induced Psoriasis-Like Dermatitis by Regulating lncRNA XIST.
Xiang S; Wu X; Xiang Y
Skin Pharmacol Physiol; 2022; 35(6):328-342. PubMed ID: 35960313
[TBL] [Abstract][Full Text] [Related]
4. Selenium-Rich Yeast Peptide Fraction Ameliorates Imiquimod-Induced Psoriasis-like Dermatitis in Mice by Inhibiting Inflammation via MAPK and NF-κB Signaling Pathways.
Guo H; Li M; Liu H
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216231
[TBL] [Abstract][Full Text] [Related]
5. Ginsenoside Compound K Reduces Psoriasis-related Inflammation by Activation of the Glucocorticoid Receptor in Keratinocytes.
Wang W; Xu X; Yang M; Jiang M; Wang D; Tang C; Wei W; Chen J
Curr Mol Pharmacol; 2024 Feb; 17():e18761429254358. PubMed ID: 38389423
[TBL] [Abstract][Full Text] [Related]
6. Serine deficiency exacerbates psoriatic skin inflammation by regulating S-adenosyl methionine-dependent DNA methylation and NF-κB signalling activation in keratinocytes.
Meng Q; Liu Y; Yao L; Ma Z; Guo L; Hu T; Luo Y; Chen J; Dang E; Li Z
J Eur Acad Dermatol Venereol; 2024 Jan; 38(1):145-156. PubMed ID: 37669859
[TBL] [Abstract][Full Text] [Related]
7. Increased βTrCP are associated with imiquimod-induced psoriasis-like skin inflammation in mice via NF-κB signaling pathway.
Li R; Wang J; Wang X; Zhou J; Wang M; Ma H; Xiao S
Gene; 2016 Oct; 592(1):164-171. PubMed ID: 27476970
[TBL] [Abstract][Full Text] [Related]
8. MiR-193b-3p-ERBB4 axis regulates psoriasis pathogenesis via modulating cellular proliferation and inflammatory-mediator production of keratinocytes.
Huang C; Zhong W; Ren X; Huang X; Li Z; Chen C; Jiang B; Chen Z; Jian X; Yang L; Liu X; Huang H; Shen C; Chen X; Dou X; Yu B
Cell Death Dis; 2021 Oct; 12(11):963. PubMed ID: 34667159
[TBL] [Abstract][Full Text] [Related]
9. Anoctamin1 Induces Hyperproliferation of HaCaT Keratinocytes and Triggers Imiquimod-Induced Psoriasis-Like Skin Injury in Mice.
Choi MR; Kim HD; Cho S; Jeon SH; Kim DH; Wee J; Yang YD
Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281197
[TBL] [Abstract][Full Text] [Related]
10. Allicin ameliorates imiquimod-induced psoriasis-like skin inflammation via disturbing the interaction of keratinocytes with IL-17A.
Zhang L; Ma X; Shi R; Zhang L; Zhao R; Duan R; Qin Y; Gao S; Li X; Duan J; Li J
Br J Pharmacol; 2023 Mar; 180(5):628-646. PubMed ID: 36355777
[TBL] [Abstract][Full Text] [Related]
11. Tranexamic acid improves psoriasis-like skin inflammation: Evidence from in vivo and in vitro studies.
Hseu JH; Chan CI; Vadivalagan C; Chen SJ; Yen HR; Hseu YC; Yang HL; Wu PY
Biomed Pharmacother; 2023 Oct; 166():115307. PubMed ID: 37573659
[TBL] [Abstract][Full Text] [Related]
12. Indirubin ameliorates imiquimod-induced psoriasis-like skin lesions in mice by inhibiting inflammatory responses mediated by IL-17A-producing γδ T cells.
Xie XJ; Di TT; Wang Y; Wang MX; Meng YJ; Lin Y; Xu XL; Li P; Zhao JX
Mol Immunol; 2018 Sep; 101():386-395. PubMed ID: 30064075
[TBL] [Abstract][Full Text] [Related]
13. Gasdermin E promotes translocation of p65 and c-jun into nucleus in keratinocytes for progression of psoriatic skin inflammation.
Long F; Wei X; Chen Y; Li M; Lian N; Yu S; Chen S; Yang Y; Li M; Gu H; Chen X
Cell Death Dis; 2024 Mar; 15(3):180. PubMed ID: 38429278
[TBL] [Abstract][Full Text] [Related]
14. Unconjugated bilirubin and its derivative ameliorate IMQ-induced psoriasis-like skin inflammation in mice by inhibiting MMP9 and MAPK pathway.
Bharatha M; Nandana MB; Praveen R; Nayaka S; Velmurugan D; Vishwanath BS; Rajaiah R
Int Immunopharmacol; 2024 Mar; 130():111679. PubMed ID: 38377853
[TBL] [Abstract][Full Text] [Related]
15. PDRN, a Bioactive Natural Compound, Ameliorates Imiquimod-Induced Psoriasis through NF-κB Pathway Inhibition and Wnt/β-Catenin Signaling Modulation.
Irrera N; Bitto A; Vaccaro M; Mannino F; Squadrito V; Pallio G; Arcoraci V; Minutoli L; Ieni A; Lentini M; Altavilla D; Squadrito F
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32059361
[TBL] [Abstract][Full Text] [Related]
16. IL-23/IL-17 immune axis mediates the imiquimod-induced psoriatic inflammation by activating ACT1/TRAF6/TAK1/NF-κB pathway in macrophages and keratinocytes.
Chen WC; Wen CH; Wang M; Xiao ZD; Zhang ZZ; Wu CL; Wu R
Kaohsiung J Med Sci; 2023 Aug; 39(8):789-800. PubMed ID: 37098777
[TBL] [Abstract][Full Text] [Related]
17. Genistein suppresses psoriasis-related inflammation through a STAT3-NF-κB-dependent mechanism in keratinocytes.
Wang A; Wei J; Lu C; Chen H; Zhong X; Lu Y; Li L; Huang H; Dai Z; Han L
Int Immunopharmacol; 2019 Apr; 69():270-278. PubMed ID: 30743203
[TBL] [Abstract][Full Text] [Related]
18. The STING antagonist H-151 ameliorates psoriasis via suppression of STING/NF-κB-mediated inflammation.
Pan Y; You Y; Sun L; Sui Q; Liu L; Yuan H; Chen C; Liu J; Wen X; Dai L; Sun H
Br J Pharmacol; 2021 Dec; 178(24):4907-4922. PubMed ID: 34460100
[TBL] [Abstract][Full Text] [Related]
19.
Zhang H; Ren C; Liu Q; Wang Q; Wang D
Allergol Immunopathol (Madr); 2023; 51(3):124-134. PubMed ID: 37169570
[TBL] [Abstract][Full Text] [Related]
20. PARP2 downregulation in T cells ameliorates lipopolysaccharide-induced inflammation of the large intestine.
Bencsics M; Bányai B; Ke H; Csépányi-Kömi R; Sasvári P; Dantzer F; Hanini N; Benkő R; Horváth EM
Front Immunol; 2023; 14():1135410. PubMed ID: 37457706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
